Back to Search
TRACY GROSSMAN, M.D.
M.D.
Maternal & Fetal Medicine Physician
NPI: 1356714950IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics & Gynecology Physician
Obstetrics & Gynecology
Code: 207V00000X
282691(NY)
Maternal & Fetal Medicine PhysicianPrimary
Obstetrics & Gynecology — Maternal & Fetal Medicine
Code: 207VM0101X
282691(NY)
CMS Specialties
PrimaryOBSTETRICS/GYNECOLOGY
Education
UNIVERSITY OF MIAMI, LM MILLER SCHOOL OF MEDICINE
Class of 2012
Research & Publications (20)
E6AP promotes the degradation of the PML tumor suppressor.
PMID 19325566·Cell Death Differ·2009
7-preclinical
c-Abl phosphorylates Hdmx and regulates its interaction with p53.
PMID 19075013·J Biol Chem·2009
8-other
Transcutaneous electrical retinal stimulation therapy for age-related macular degeneration.
PMID 19526044·Open Ophthalmol J·2008
8-other
Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.
PMID 18690678·J Med Chem·2008
7-preclinical
Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds.
PMID 17116675·Antimicrob Agents Chemother·2007
8-other
Association of a high-molecular weight arginine-binding protein of Fusobacterium nucleatum ATCC 10953 with adhesion to secretory immunoglobulin A and coaggregation with Streptococcus cristatus.
PMID 17600532·Oral Microbiol Immunol·2007
8-other
Impact of the molecular form of immunoglobulin A on functional activity in defense against Streptococcus pneumoniae.
PMID 17261616·Infect Immun·2007
8-other
In vitro characterization of the antibacterial spectrum of novel bacterial type II topoisomerase inhibitors of the aminobenzimidazole class.
PMID 16569833·Antimicrob Agents Chemother·2006
8-other
Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
PMID 16492148·Chem Biol Drug Des·2006
4-observational
Fusobacterium nucleatum transports noninvasive Streptococcus cristatus into human epithelial cells.
PMID 16369022·Infect Immun·2006
8-other
Inhibition of antibiotic efflux in bacteria by the novel multidrug resistance inhibitors biricodar (VX-710) and timcodar (VX-853).
PMID 15504837·Antimicrob Agents Chemother·2004
8-other
Multifarious characterization of leishmania tropica from a Judean desert focus, exposing intraspecific diversity and incriminating phlebotomus sergenti as its vector.
PMID 15100448·Am J Trop Med Hyg·2004
7-preclinical
The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation.
PMID 12810724·J Biol Chem·2003
7-preclinical
Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance.
PMID 12604539·Antimicrob Agents Chemother·2003
8-other
Differential effect of pH on sodium binding by the various GABA transporters expressed in Xenopus oocytes.
PMID 12220647·FEBS Lett·2002
7-preclinical
Multiple inhibitor analysis of the brequinar and leflunomide binding sites on human dihydroorotate dehydrogenase.
PMID 11329288·Biochemistry·2001
8-other
Expression and isolation of antimicrobial small molecules from soil DNA libraries.
PMID 11321587·J Mol Microbiol Biotechnol·2001
8-other
Sequence analysis and functional characterization of the violacein biosynthetic pathway from Chromobacterium violaceum.
PMID 11075927·J Mol Microbiol Biotechnol·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 566 6H ST
BROOKLYN, NY 11215 - Phone
- (718) 780-3000
Quick Facts
- NPI
- 1356714950
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 14
- Publications
- 20
Are you this provider?
Claim Your Profile